Drosophila is a widely used experimental model suitable for screening drugs with potential applications for cancer therapy. Here, we describe the use of Drosophila variegated eye color phenotypes as a method for screening small-molecule compounds that promote heterochromatin formation.

A Screening Method for Identification of Heterochromatin-Promoting Drugs Using Drosophila

•

•

•

Chapters

Summary

Automatic Translation

Tags

Article

Embed

ADD TO PLAYLIST

Usage Statistics

Related Videos

High Resolution Fluorescent In Situ Hybridization in Drosophila Embryos and Tissues Using Tyramide Signal Amplification

Efficient Production and Identification of CRISPR/Cas9-generated Gene Knockouts in the Model System Danio rerio

High-throughput Identification of Synergistic Drug Combinations by the Overlap² Method

High-throughput Identification of Gene Regulatory Sequences Using Next-generation Sequencing of Circular Chromosome Conformation Capture (4C-seq)

Screening Cotton Genotypes for Reniform Nematode Resistance

High-Throughput DNA Plasmid Multiplexing and Transfection Using Acoustic Nanodispensing Technology

Identification of Circular RNAs using RNA Sequencing

Use of Drosophila S2 Cells for Live Imaging of Cell Division

Screening and Identification of RNA Silencing Suppressors from Secreted Effectors of Plant Pathogens

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Read Article